Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL488P is a pseudogene corresponding to the cytoplasmic 7SL RNA gene family in humans[2]. True 7SL RNA (not the pseudogene) is an essential component of the signal recognition particle, which is involved in targeting proteins to the endoplasmic reticulum for secretion or membrane integration[1][3]. Pseudogenes, including RN7SL488P, are by definition genomic sequences resembling functional genes but typically lack any protein-coding capability due to mutations, truncation, or other disruptions[5][6]. The RN7SL488P locus is annotated as a non-coding pseudogene, meaning it does not encode any protein nor does it serve as a conventional drug target such as a receptor, ion channel, transporter, or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 488, pseudogene (RN7SL488P).